Retraction
MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a
Paper Information
Record ID:
30969
Journal:
Publication Date:
December 17, 2015
Retraction Date:
July 05, 2021
(4.4 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (31)
31
Total Citations2
Post-Retraction(6.5%)
29
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
158
Days since retraction (latest)
Osteosarcoma and Metastasis
Gaohong Sheng, Yuan Gao, Yang Yong et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Dec 2021
135 citations
135 citations
158 days after retraction
Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma
Foroogh Hosseini, Forough Alemi, Faezeh Malakoti et al. (7 authors)
Biochemical Pharmacology
Published: Sep 2021
20 citations
20 citations
60 days after retraction
Expression and Regulatory Network Analysis of Function of Small Nucleolar RNA Host Gene 4 in Hepatocellular Carcinoma
Jing Cao, Cuicui Xiao, Christ-Jonathan Tsia Hin Fong et al. (8 authors)
Journal of Clinical and Translational Hepatology
Open Access
Published: Jul 2021
8 citations
8 citations
3 days before retraction
<p>MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers</p>
Ali Nazarizadeh, Forogh Mohammadi, Fatemeh Alian et al. (6 authors)
OncoTargets and Therapy
Open Access
Published: Jul 2020
11 citations
11 citations
369 days before retraction
A comprehensive analysis for associations between multiple microRNAs and prognosis of osteosarcoma patients.
Wen Yang, Yubin Qi, Meng Si et al. (5 authors)
DOAJ (DOAJ: Directory of Open Access Journals)
Published: Jan 2020
6 citations
6 citations
551 days before retraction
Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
Zahra Bolandghamat Pour, Mitra Nourbakhsh, Kazem Mousavizadeh et al. (8 authors)
BMC Cancer
Open Access
Published: Nov 2019
32 citations
32 citations
612 days before retraction
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
Rémy Nicolle, Mira Ayadi, Anne Gomez‐Brouchet et al. (20 authors)
Nature Communications
Open Access
Published: Oct 2019
84 citations
84 citations
633 days before retraction
Down-regulation of NAMPT expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
Zahra Bolandghamtpour, Mitra Nourbakhsh, Kazem Mousavizadeh et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Oct 2019
642 days before retraction
Down-regulation of NAMPT expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
Zahra Bolandghamtpour, Mitra Nourbakhsh, Kazem Mousavizadeh et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Oct 2019
642 days before retraction
miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling
Que Wang, Xiaoxue Yu, Lin Dou et al. (12 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Sep 2019
26 citations
26 citations
662 days before retraction
<p>MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma</p>
Dongliang Shi, Haiyan Wang, Mingjian Ding et al. (7 authors)
OncoTargets and Therapy
Open Access
Published: Aug 2019
39 citations
39 citations
704 days before retraction
MicroRNA-154 Targets the Wnt/β-Catenin Signaling Pathway Following Injury to Human Vascular Endothelial Cells by Hydrogen Peroxide
Yan Li, Ranran Meng
Medical Science Monitor
Open Access
Published: Jul 2019
2 citations
2 citations
706 days before retraction
Down-regulation of NAMPT expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
Zahra Bolandghamtpour, Mitra Nourbakhsh, Kazem Mousavizadeh et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Jun 2019
746 days before retraction
Retraction Note: Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma
Renzeng Li, Limin Wang
World Journal of Surgical Oncology
Open Access
Published: Jun 2019
3 citations
3 citations
752 days before retraction
SNHG5 Promotes Breast Cancer Proliferation by Sponging the miR-154-5p/PCNA Axis
Jiangrui Chi, Zhihao Yu, Bowen Liu et al. (7 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: Jun 2019
77 citations
77 citations
762 days before retraction
MicroRNA‐195 suppresses the progression of lung adenocarcinoma by directly targeting apelin
Yongchun Zhou, Ming Zhao, Yaxi Du et al. (13 authors)
Thoracic Cancer
Open Access
Published: May 2019
26 citations
26 citations
788 days before retraction
miRNA signatures in childhood sarcomas and their clinical implications
G. M. Viera, Karina Bezerra Salomão, Graziella Ribeiro de Sousa et al. (7 authors)
Clinical & Translational Oncology
Published: Apr 2019
15 citations
15 citations
823 days before retraction
Velvet Antler compounds targeting major cell signaling pathways in osteosarcoma - a new insight into mediating the process of invasion and metastasis in OS
Zhengyao Zhang, Pengfei Li, Tie Li et al. (5 authors)
Open Chemistry
Open Access
Published: Mar 2019
2 citations
2 citations
829 days before retraction
Gonadotrophin-mediated miRNA expression in testis at onset of puberty in rhesus monkey: predictions on regulation of thyroid hormone activity and DLK1-DIO3 locus
Paula Aliberti, Rahil Sethi, Alicia Belgorosky et al. (6 authors)
Molecular Human Reproduction
Open Access
Published: Dec 2018
10 citations
10 citations
927 days before retraction
miR-222-3p promotes osteosarcoma cell migration and invasion through targeting TIMP3
Guo Jian-ping, Quanxiang Liu, Zengxin Li et al. (6 authors)
OncoTargets and Therapy
Open Access
Published: Dec 2018
26 citations
26 citations
947 days before retraction
<i>miR-34</i> inhibits growth and promotes apoptosis of osteosarcoma in nude mice through targetly regulating TGIF2 expression
Xi Liang, Yongfeng Zhang, Shengnan Kong et al. (4 authors)
Bioscience Reports
Open Access
Published: Jun 2018
26 citations
26 citations
1119 days before retraction
Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway
Hongquan Chen, Dong Gao
The International Journal of Biochemistry & Cell Biology
Published: May 2018
12 citations
12 citations
1161 days before retraction
MicroRNA‑154 functions as a tumor suppressor in non‑small cell lung cancer through directly targeting B‑cell‑specific Moloney murine leukemia virus insertion site 1
Sida Liu, Yang� Yang, Lu Chen et al. (5 authors)
Oncology Letters
Open Access
Published: Apr 2018
12 citations
12 citations
1165 days before retraction
MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A
Meiyue Liu, Yue Zhang, Jie Zhang et al. (14 authors)
Cell Death and Disease
Open Access
Published: Feb 2018
70 citations
70 citations
1244 days before retraction
MiRNomics Reveals Breast Cancer Cells Cultured on 3D Scaffolds Better Mimic Tumors in Vivo than Conventional 2D Culture
Gowri Manohari Balachander, Balaji Rajashekar, Prasad M. Sarashetti et al. (5 authors)
ACS Biomaterials Science & Engineering
Published: Dec 2017
11 citations
11 citations
1307 days before retraction
ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a
Bin Dai, Ting Yan, Ailiang Zhang
Cancer Cell International
Open Access
Published: Nov 2017
24 citations
24 citations
1314 days before retraction
Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection
Carolina Stenfeldt, Jonathan Arzt, George R. Smoliga et al. (6 authors)
Virology Journal
Open Access
Published: Apr 2017
33 citations
33 citations
1550 days before retraction
MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a.
Yu-Chun Wang, Cong Xu, X Zhang
PubMed
Published: Jan 2017
31 citations
31 citations
1646 days before retraction
RETRACTED ARTICLE: Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma
Renzeng Li, Limin Wang
World Journal of Surgical Oncology
Open Access
Published: May 2016
18 citations
18 citations
1874 days before retraction
MicroRNA-494 inhibits proliferation and metastasis of osteosarcoma through repressing insulin receptor substrate-1.
Xiaodong Zhi, Kai Wu, Deshui Yu et al. (7 authors)
PubMed
Published: Jan 2016
24 citations
24 citations
2012 days before retraction
MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5.
Hui Xu, Dan Fei, Shan Zong et al. (4 authors)
PubMed
Published: Jan 2016
58 citations
58 citations
2012 days before retraction
Quick Stats
Total Citations:
31
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025